Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Regulatory Filings 2010

Oct 12, 2010

29777_rf_2010-10-12_f807121a-1c9b-43e3-a853-2661c4c7a923.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

S-8 1 a10-18909_2s8.htm S-8

*As filed with the Securities and Exchange Commission on October 12, 2010.*

*Registration No. 333-*

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM S-8*

*REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933*

*Abbott Laboratories*

(Exact name of registrant as specified in its charter)

Illinois 36-0698440
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
Abbott Laboratories
100 Abbott Park Road
Abbott Park, Illinois 60064-6400
(Address of Principal Executive Offices) (Zip Code)

*ABBOTT LABORATORIES STOCK RETIREMENT PROGRAM*

(Full title of the plan)

*Laura J. Schumacher*

*Abbott Laboratories*

*100 Abbott Park Road*

*Abbott Park, Illinois 60064-6400*

(Name and address of agent for service)

Telephone number, including area code, of agent for service: (847) 937-6100

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer x Accelerated filer o
Non-accelerated filer o Smaller reporting
company o
(Do not check if a smaller
reporting company)

*CALCULATION OF REGISTRATION FEE*

Title of securities to be registered Amount to be registered Proposed maximum offering price per share (a) Proposed maximum aggregate offering price (a) Amount of registration fee (a)
Common shares (without par value) 19,500,000 $ 52.67 $ 1,027,065,000 $ 73,230

(a) In addition, pursuant to Rule 416(c) under the Securities Act of 1933, this registration statement also covers an indeterminate amount of interests to be offered or sold pursuant to the employee benefit plan described herein. The filing fee has been calculated in accordance with Rule 457(c) based on the average of the high and low prices of Registrant’s Common Shares reported on the New York Stock Exchange on October 8, 2010.

SEQ.=1,FOLIO='',FILE='C:\JMS\105735\10-18909-2\task4302389\18909-2-ba.htm',USER='105735',CD='Oct 12 19:12 2010'

Pursuant to General Instruction E, the contents of Abbott Laboratories Stock Retirement Program Registration Statement on Form S-8 (File no. 33-50452) are incorporated herein by reference.

Part II. Information Required in the Registration Statement

Item 8. Exhibits

Reference is made to the Exhibit Index which is incorporated herein by reference. Neither an opinion of counsel concerning the Program’s compliance with the requirements of ERISA nor an Internal Revenue Service (“IRS”) determination letter is furnished because the Registrant undertakes that it will submit, or has submitted, the Abbott Laboratories Stock Retirement Program and any amendments thereto to the IRS in a timely manner and has made or will make all changes required by the IRS in order to qualify the Program.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\105735\10-18909-2\task4302389\18909-2-ba.htm',USER='105735',CD='Oct 12 19:12 2010'

SIGNATURES

THE REGISTRANT. Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in unincorporated Lake County, and State of Illinois, on October 12, 2010.

| ABBOTT
LABORATORIES | |
| --- | --- |
| By: | /s/
Miles D. White |
| | Miles
D. White, |
| | Chairman
of the Board and |
| | Chief
Executive Officer |

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\105735\10-18909-2\task4302389\18909-2-ba.htm',USER='105735',CD='Oct 12 19:12 2010'

Each person whose signature appears below constitutes and appoints Miles D. White and Laura Schumacher, Esq., and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Signature Title Date
/s/ Miles D. White Chairman of the Board, October
12, 2010
Miles D. White Chief Executive Officer,
and
Director
/s/ Thomas C. Freyman Executive Vice President,
Finance and October
12, 2010
Thomas C. Freyman Chief Financial Officer
(Principal
Financial Officer)
/s/
Greg W. Linder Vice President and
Controller October
12, 2010
Greg W. Linder (Principal Accounting
Officer)
/s/ Robert J. Alpern M.D. Director October
12, 2010
Robert J. Alpern M.D.
/s/ Roxanne S. Austin Director October
12, 2010
Roxanne S. Austin
/s/ William M. Daley Director October
12, 2010
William M. Daley
/s/ W. James Farrell Director October
12, 2010
W. James Farrell
/s/ H. Laurance Fuller Director October
12, 2010
H. Laurance Fuller

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\105735\10-18909-2\task4302389\18909-2-ba.htm',USER='105735',CD='Oct 12 19:12 2010'

Director October , 2010
Edward M. Liddy
/s/ Phebe N. Novakovic Director October
12, 2010
Phebe N. Novakovic
/s/ William A. Osborn Director October
12, 2010
William A. Osborn
/s/ David A. L. Owen Director October
12, 2010
David A. L. Owen
/s/ Roy S. Roberts Director October
12, 2010
Roy S. Roberts
/s/ Samuel C. Scott III Director October
12, 2010
Samuel C. Scott III
/s/ William D. Smithburg Director October
12, 2010
William D. Smithburg
/s/ Glenn F. Tilton Director October
12, 2010
Glenn
F. Tilton

5

SEQ.=1,FOLIO='5',FILE='C:\JMS\105735\10-18909-2\task4302389\18909-2-ba.htm',USER='105735',CD='Oct 12 19:12 2010'

THE PLAN. Pursuant to the requirements of the Securities Act of 1933, the Abbott Laboratories Stock Retirement Program has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in unincorporated Lake County, and State of Illinois, on the 12th day of October, 2010.

| ABBOTT
LABORATORIES STOCK RETIREMENT PROGRAM | |
| --- | --- |
| By: | /s/
Stephen R. Fussell |
| | Stephen
R. Fussell, Plan Administrator |

6

SEQ.=1,FOLIO='6',FILE='C:\JMS\105735\10-18909-2\task4302389\18909-2-ba.htm',USER='105735',CD='Oct 12 19:12 2010'

EXHIBIT INDEX

Exhibit No. Description
23.1 Consent
of Deloitte & Touche LLP.
23.2 Consent
of Grant Thornton LLP.
24 Power
of Attorney is included on the signature page.

7

SEQ.=1,FOLIO='7',FILE='C:\JMS\105735\10-18909-2\task4302389\18909-2-ba.htm',USER='105735',CD='Oct 12 19:12 2010'